Calcium channel blockers for acute traumatic brain injury

J Langham1, C Goldfrad, G Teasdale

  • 1R&D Public Health, Kensington, Chelsea and Westminster Health Authority, 50 Eastbourne Terrace, London, UK, W2 6LX. julia.langham@ha.kcw-ha.nthames.nhs.uk

Insights

Calcium channel blockers show uncertain effects for acute traumatic brain injury patients. However, nimodipine may benefit those with subarachnoid hemorrhage, despite potential adverse reactions.

Area of Science:

  • Neuroscience
  • Pharmacology
  • Critical Care Medicine

Background:

  • Acute traumatic brain injury (TBI) is a significant cause of mortality and long-term disability.
  • Calcium channel blockers (CCBs) are investigated for mitigating secondary brain injury by preventing cerebral vasospasm and maintaining cerebral blood flow.

Purpose of the Study:

  • To systematically evaluate the efficacy of calcium channel blockers in patients with acute traumatic brain injury.
  • To assess the effects of CCBs in a specific subgroup of TBI patients with traumatic subarachnoid hemorrhage.

Main Methods:

  • A comprehensive search of electronic databases and hand searching was conducted for randomized controlled trials (RCTs) up to October 1997.
  • Eligibility criteria included RCTs involving patients with clinically diagnosed acute TBI of any severity.
  • Data extraction and eligibility assessment were performed independently by two reviewers, with pooled odds ratios calculated using the Mantel-Haenszel method.

Main Results:

  • Four eligible RCTs were identified. Overall, CCBs did not significantly reduce the risk of death (OR 0.91, 95% CI 0.70-1.17) or death/severe disability (OR 0.85, 95% CI 0.68-1.07).
  • In the subgroup of patients with traumatic subarachnoid hemorrhage, CCBs showed a trend towards reduced risk of death (OR 0.59, 95% CI 0.37-0.94) and significantly reduced death or severe disability (OR 0.67, 95% CI 0.46-0.98).

Conclusions:

  • The overall effect of calcium channel blockers in acute TBI remains uncertain due to limited evidence.
  • Nimodipine demonstrated a potential beneficial effect in TBI patients with subarachnoid hemorrhage, but increased adverse events warrant careful consideration of its risk-benefit profile.
Abstract

Related Concept Videos

Ligand-Gated Ion Channel Receptor: Gating Mechanism01:30

Ligand-Gated Ion Channel Receptor: Gating Mechanism

Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Transient Ischemic Attack l: Introduction01:26

Transient Ischemic Attack l: Introduction

A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
Traumatic Brain Injury l: Introduction01:28

Traumatic Brain Injury l: Introduction

DefinitionTraumatic brain injury, or TBI, is a disturbance of normal brain function induced by an external mechanical force, such as a direct blow to the head or a penetrating injury. It can affect both brain structure and function, producing a wide range of clinical outcomes. TBI is a heterogeneous condition, meaning its effects may differ based on the type, location, and severity of the injury.Basis of ClassificationTBI is classified based on severity, injury mechanism, or pathophysiology. In...
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
Secondary Spinal Cord Injury llI: Pathophysiology01:25

Secondary Spinal Cord Injury llI: Pathophysiology

Early Ischemia and Ionic ImbalanceWithin minutes of spinal cord injury, a secondary cascade begins, progressing over hours to weeks. Vascular damage reduces blood flow, causing ischemia and mitochondrial dysfunction. ATP depletion leads to ion pump failure, membrane depolarization, sodium influx, potassium efflux, and water accumulation, resulting in cellular swelling. Increased intracellular calcium further disrupts mitochondria and accelerates cellular injury.Excitotoxicity and Neuronal...